Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

Yahoo FinanceNov 22 11:31 ET

How Is The Market Feeling About Viking Therapeutics?

BenzingaNov 22 11:15 ET

Viking Therapeutics Analyst Ratings

BenzingaNov 22 08:24 ET · Ratings

B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109

Moomoo NewsNov 21 20:32 ET · Ratings

Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program

TipRanksNov 21 20:15 ET

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

Analyst UpgradesNov 20 13:26 ET